Dasatinib (Startax) medical insurance reimbursement price

Dasatinib (Dasatinib) is an oral anti-leukemia drug that belongs to the tyrosine kinase inhibitor class of drugs and is commonly used to treat chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).

Dasatinib (Dasatinib) is currently on the market in China and has been included in medical insurance. Patients can purchase it domestically at a price of about four to five thousand. For specific prices and medical insurance reimbursement, please consult the local hospital pharmacy. The cheaper foreign drug is the generic drug of Dasatinib (Sidazad), which costs about a few hundred yuan, which is much cheaper than domestically. The ingredients of the original drug on the market in China are basically the same as those of foreign generic drugs.

As a targeted therapy drug, Dasatinib (Startase) ’s main mechanism of action is to block the growth and proliferation of leukemia cells by inhibiting the activity of tyrosine kinases. In patients with CML, dasatinib (Startase) is usually used to treat Philadelphiachromosome-positive (Ph+) CML. This chromosomal abnormality results in the creation of a gene called the BCR-ABL fusion, which is one of the major causes of CML. Dasatinib (Startase) can inhibit the activity of BCR-ABL kinase, thereby reducing the number of abnormal cells and slowing down the progression of the disease.

In addition,dasatinib (Startase) is also used to treat some patients with acute lymphoblastic leukemia, especially those with Philadelphiachromosome-positive ALL.

In clinical applications, dasatinib (Startase) is usually administered orally once daily. Treatment doses and regimens may vary depending on the patient's specific condition and are usually adjusted by the physician based on the patient's disease stage, clinical manifestations, and other factors.

AlthoughDasatinib (Startaxed)It has achieved remarkable results in treating leukemia, but it may also cause some side effects, such as nausea, vomiting, diarrhea, fatigue, etc. Serious side effects may include thrombocytopenia, abnormal liver function, arrhythmia, etc., so patients need to be closely monitored and communicate with their doctors during the use of Dasatinib.